Sonya Del Tredici and John Keenan
Sonya Del Tredici and John Keenan
35. Prior Auths and Buprenorphine
35. Prior Auths and Buprenorphine
35. Prior Auths and Buprenorphine
Monday 1st January 2024
Explore how Medicaid prior authorizations affect buprenorphine prescribing and the challenges in treating stimulant use disorders with Drs. Del Tredici and Keenan.
38 minutes
Informative
Empowering
Engaging
Educational
Supportive
About this podcast
Author:
Sonya Del Tredici and John Keenan
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Navigating Intimate Relationships
Family Recovery from Addiction
Nutritional Pathways to Recovery
Episodes:
56 (View all)
Do you want to link to this podcast?
Get the buttons here!Medicaid Hurdles: Buprenorphine Access and Stimulant Use Disorder Challenges
Episode Overview
- Dr. Deltredici and Dr. Keenan analyze the impact of Medicaid prior authorization on buprenorphine prescribing.
- The hosts discuss the challenges in treating stimulant use disorder and the effects of buprenorphine diversion.
- Insights are shared on a state-level study, highlighting the complex relationship between prior authorizations and buprenorphine treatment.
- The hosts respond to feedback from the lead author of a previously reviewed paper, enriching the conversation with additional perspectives.
- Dr. Deltredici and Dr. Keenan emphasize the importance of eliminating barriers to prescribing, making it more appealing to provide essential services.
I think getting other docs, other APPs prescribing is always something that we're always talking about. I think that other people should join in this effort. So I think that, you know, even if it's a real, if it's real or perceived, I think just elimination of this, especially if it's cost effective and the right thing to do, it's a win for everyone. It just kind of makes it more appealing to provide these services.
Imagine a world where getting life-saving medication doesn't involve jumping through hoops. In this episode of 'Addiction Medicine Journal Club', Dr. Sonya Del Tredici and Dr. John Keenan tackle the issue of Medicaid prior authorizations and their impact on buprenorphine prescribing for opioid use disorder. They dig into a state-level study, offering a deep dive into whether removing these bureaucratic barriers actually leads to more people getting the treatment they need.
But that's not all—this episode also sheds light on the frustrating lack of effective treatments for stimulant use disorders like cocaine and meth addiction. Using a harm reduction lens, the hosts explore the nuances of buprenorphine diversion and its broader implications. As always, Drs. Del Tredici and Keenan keep things engaging and informative, making complex topics accessible to everyone, whether you're in the medical field or just curious about addiction treatment.
Tune in to hear their thoughts, backed by solid research and real-world experience, and get a better understanding of how policy changes can make or break access to essential care.